AcrySof IQ Vivity® IOL
Simplifying Presbyopia
Correction1-8
The First and Only presbyopia-correcting IOL
with wavefront-shaping technology and a clinically
proven low rate of visual disturbances1-4
AcrySof IQ Vivity® IOL
Simplifying Presbyopia Correction1-8
The First and Only presbyopia-correcting IOL with wavefront-shaping technology and a clinically proven low rate of visual disturbances1-4
Hear What Surgeons Are Saying About The AcrySof IQ Vivity® IOL
“This is a really exciting lens… We have been looking for it for a while.”
- Dr. Michael Lawless, MBBS, FRANZCO, FRACS
Surgeon Benefits
“The wavefront is actually shaped to be more beneficial to the visual quality and to the visual disturbance profile.” - Dr. Cathleen McCabe, MD
Patient Benefits
“The self-reported patient happiness is the best and nicest support I can get to keep doing what I do.” - Dr. Chandra Bala, PhD, MB, BS (Hons), FRANZCO
Opportunities for Surgeons Not Implanting AcrySof IQ Vivity® IOL
“I would definitely recommend this IOL to my peers who are currently not using presbyopia-correcting IOLs.” - Dr. Devesh Varma, MD
Results from 2 Large Independent Trials:
AcrySof IQ Vivity® IOL Delivers Excellent Distance, Intermediate and Functional Near Vision3,4
20/20
Binocular Mean
Uncorrected Distance
Visual Acuity (4 m)*
DISTANCE
Better Than 20/25
Binocular Mean
Uncorrected Intermediate
Visual Acuity (66 cm)*
INTERMEDIATE
20/32
Binocular Mean
Uncorrected Near
Visual Acuity (40 cm)*
NEAR
*Binocular uncorrected visual acuity results from a prospective, randomised, parallel group, subject- and assessor-masked, multisite trial of 107 subjects bilaterally implanted with the AcrySof IQ Vivity® Extended Vision IOL and 113 with the AcrySof® IQ IOL with 6 months’ follow-up.
In All Light Conditions, AcrySof IQ Vivity® IOL Patients Reported Monofocal-Quality Distance With Excellent Intermediate and Functional Near Vision4
Percent of Patients Reporting Good or Very Good Vision Without Spectacles at 6 Months in Validated IOLSAT Questionnaire4*†
*Patients were asked, “How well did you see without wearing eyeglasses in the past 7 days?”
†Results from a prospective, randomised, parallel group, subject and assessor masked, multisite trial of 107 subjects bilaterally implanted with the AcrySof IQ Vivity® Extended Vision IOL and 113 with the AcrySof® IQ IOL with 6 months follow-up.
AcrySof IQ Vivity® IOL Visual Disturbance Profile is Comparable to the AcrySof® IQ Monofocal1,3,4
The majority of AcrySof IQ Vivity® IOL patients were not bothered at all by visual disturbances.4
Degree of Bother (%)*
Diffractive trifocal technology IOLs can deliver reduced spectacle dependence, but it’s not for every patient. Some patients are not candidates due to low tolerance for visual disturbances or other ocular health problems.11-13
*Results from a prospective, randomised, parallel group, subject and assessor masked, multisite trial of 107 subjects bilaterally implanted with AcrySof IQ Vivity® Extended Vision IOL and 113 with AcrySof® IQ IOL with 6 months follow-up. Visual disturbances were evaluated subjectively through QUVID questionnaire. Patients were asked: “In the past 7 days, how much were you bothered with starbursts, halos, and glare?”
Visual Disturbance Profile: AcrySof IQ Vivity® Had an Optical Halo Comparable to a Monofocal IOL5
Optical Bench Halo Measurements (4.5 mm Pupil Size)
AcrySof® IQ
Monofocal IOL
AcrySof IQ Vivity®
IOL Wavefront-Shaping
Technology
TECNIS Symfony*
Diffractive EDoF
ZEISS AT LARA* 829 MP Diffractive EDoF
These are representative images from a benchtop study.
*Trademarks are property of their respective owners.
AcrySof IQ Vivity® IOL is the First and Only presbyopia-correcting IOL that uses a next generation optical principle, called wavefront-shaping, that stretches and shifts the light1-4
✓ The AcrySof IQ Vivity® IOL uses wavefront-shaping technology, which is invisible to the naked eye, making it virtually indistinguishable from the AcrySof® IQ monofocal1,2
✓ Surface Transition #1: A slightly elevated smooth plateau (~1 µm high) that stretches the wavefront, creating a continuous focal range2
✓ Surface Transition #2: A small curvature change (across the 2.2 mm region) that shifts the wavefront to utilize all available light energy2
AcrySof IQ Vivity® IOL is the First and Only presbyopia-correcting IOL that uses a next generation optical principle, called wavefront-shaping, that stretches and shifts the light1-4
✓ The AcrySof IQ Vivity® IOL uses wavefront-shaping technology, which is invisible to the naked eye, making it virtually indistinguishable from the AcrySof® IQ monofocal1,2
✓ Surface Transition #1: A slightly elevated smooth plateau (~1 µm high) that stretches the wavefront, creating a continuous focal range2
✓ Surface Transition #2: A small curvature change (across the 2.2 mm region) that shifts the wavefront to utilize all available light energy2
AcrySof IQ Vivity® IOL is the First and Only presbyopia-correcting IOL that uses a next generation optical principle, called wavefront-shaping, that stretches and shifts the light1-4
✓ The AcrySof IQ Vivity® IOL uses wavefront-shaping technology, which is invisible to the naked eye, making it virtually indistinguishable from the AcrySof® IQ monofocal1,2
✓ Surface Transition #1: A slightly elevated smooth plateau (~1 µm high) that stretches the wavefront, creating a continuous focal range2
✓ Surface Transition #2: A small curvature change (across the 2.2 mm region) that shifts the wavefront to utilize all available light energy2
Unique Mechanism of Action
The AcrySof IQ Vivity® IOL uses wavefront-shaping technology to deliver distance, intermediate, and functional near vision for patients, as well as a clinically proven low rate of visual disturbances.1-4
The wavefront-shaping technology of the AcrySof IQ Vivity® IOL is called X-WAVE™ Technology and is proprietary to Alcon.
Wavefront-shaping stretches the light. It doesn’t bend light like refraction, or split light like diffraction.
Similar to a monofocal, Vivity® utilizes essentially all of the transmitted light energy that passes through the lens. The smooth surface transition elements on the AcrySof IQ Vivity® IOL stretch and shift the wavefront to provide a full range of vision with functional near visual acuity to help reduce spectacle dependence.1-4
What is Vivity®?
AcrySof IQ Vivity® wavefront-shaping technology explained.
Surface Transition Elements Affect Light Energy Distribution*
The proprietary, wavefront-shaping design creates a monofocal visual disturbance profile and a continuous range of vision for patients.1-4 With the AcrySof IQ Vivity® IOL, light spans a continuous focal range, instead of being split amongst multiple focal points.9
*Simulated photopic through-focus point spread function (light intensity [energy]) – polychromatic.
†Trademarks are the property of their respective owners.
The Flat Defocus Curve Delivers Confidence in Hitting a Refractive Target With AcrySof IQ Vivity® IOL3
6-Month Binocular Distance Corrected Visual Acuity3*
A refractive miss of +/- 0.5D can still leave a patient with VA of 20/20
*Data obtained from a prospective, randomised, controlled study of bilateral implantation of 106 AcrySof IQ Vivity® patients and 111 AcrySof® IQ monofocal IOL patients from a computerised visual acuity test system.
6-Month Binocular Distance Corrected Visual Acuity3*
AcrySof IQ Vivity® IOL patients experience a continuous extended range of vision from distance to as close as 50 cm
See Why Patients Say The AcrySof IQ Vivity® IOL
Was The Right Choice For Them
“I’m extremely excited about my vision…it’s kind of like I’ve got new eyes. The Vivity® lens provided a terrific outcome for me.”
- Tracey, USA
Tracey, USA
Tracey is like many patients whose active lifestyle makes them best suited for a lens that can offer them a continuous range of vision.1
Mike, USA
Mike is representative of patients who participated in the global AcrySof IQ Vivity® IOL studies, reporting 20/20 distance VA, >20/25 intermediate distance VA (66 cm), and 20/32 near VA (40 cm).1
Dr. Angela Jennings, Australia
Dr. Angela Jennings is an ophthalmologist and an AcrySof IQ Vivity® IOL patient who represents many patients who are considered unsuitable for PCIOLs; these include people with Type A personalities, people who drive at night, and who have mild glaucoma.1
Elena, Spain
Elena is like many patients who are most suited for a lens with a continuous range of vision in order to maintain their hobbies and active lifestyle.1
The patients that appear in these videos express opinions that are their own, based on their own experiences. These videos are not a substitute for medical advice or information. The patients received a modest compensation for their participation in these videos.
Clinical Support
Technical Specifications1,10
Instructions for Use (IFU)
For a full list of indications, contraindications and warnings, please visit ifu.alcon.com and refer to the relevant product’s instructions for use.
Alcon Experience Academy
For relevant training content from industry thought leaders
References
1. Acrysof IQ Vivity® Extended Vision IOL Global Directions for Use.
2. Alcon Data on File, 2018.
3. Bala C, et al. Multi-country clinical outcomes of a new non-diffractive presbyopia-correcting IOL. J Cataract Refract Surg. 2021; DOI:10.1097/j.jcrs.0000000000000712.
4. McCabe C, Berdahl J, Reiser H, et al. Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a non-diffractive design. J Cataract Refract Surg. 2022;48(11):1297-1304.doi:10.1097/j. jcrs.0000000000000978.
5. Baur I, et al. Visualization of ray propagation through extended depth-of-focus intraocular lenses. Diagnostics 2022, 12, 2667. https://doi.org/10.3390/diagnostics12112667.
6. Ligabue E, et al. ACRYSOF IQ VIVITY: Natural vision at a range of distances provided by a novel optical technology. Cataract & Refractive Surgery Today. April 2020 //
7. Lawless M. Insighnews. "An IOL to change the cataract surgery paradigm?" available at "https://www.insightnews.com.au/an-iol-to-change-the-cataract-surgery-paradigm/". Accessed Date 17.07.2020.
8. Ike K. Ahmed, et al. The Vivity Extended Depth of Focus IOL: Our Clinical Experience. Cataract & Refractive Surgery Today. February 2021//
9. Kohnen T, et al. The Novel Optical Design and Clinical Classification of a Wavefront-Shaping Presbyopia-Correcting Intraocular Lens. Clinical Ophthalmology. 2023:17 2449–2457.
10. AcrySof IQ Vivity® Toric Extended Vision IOL Directions for Use.
11. Braga-Mele R, et al. Multifocal intraocular lenses: relative indications and contraindications for implantation. J Cataract Refract Surg. 2014;40(2):313-322.
12. Gundersen KG, et al. Retreatments after multifocal intraocular lens implantation: an analysis. Clin Ophthalmol. 2016:10;365–371.
13. Zvornicanin J, et al. Premium intraocular lenses: The past, present and future. J Curr Ophthalmol. 2018;30(4):287-296.
For indications, contraindications and warnings, please refer to the relevant product's instruction for use.